Almonds are highly nutritious and one of the world's most popular tree nuts. They are rich in healthy fats, antioxidants, vitamins, and minerals.
A one-ounce serving of almonds contains 3.5 grams of fiber, six grams of protein, 14 grams of fat, nine of which are monounsaturated, 37 percent of vitamin E, 32 percent of manganese and 20 percent of magnesium.
Almonds also contain copper, vitamin B2, and phosphorus.
The magnesium in almonds is the reason why it is recommended for those who have high blood pressure or those who are hypertensive.
If you have high blood pressure and you leave it untreated, it can put you at risk of life-threatening medical conditions like heart attacks, strokes, and kidney failure.
According to studies, there is a link in magnesium deficiency and high blood pressure. It is said that when you correct your magnesium intake, it can lead to lowering your blood pressure.
Thus, health experts have concluded that adding almonds to your diet can help you in controlling your blood pressure.
One other way that almonds can lower your risk for heart attacks and stroke is that it can also lower your cholesterol level. Eating one or two handfuls of almonds a day can help in regulating the level of cholesterol in your blood.
And, almonds have also been cited to lower high levels of blood sugar. It is recommended for diabetic people because it is low in carbohydrates and high in healthy fats, protein, and fiber.
The antioxidants in almonds can help protect the cells in your body from oxidative damage that can lead to inflammation, aging, and diseases like cancer.
And, almonds can also boost your weight loss plan because snacking on this nut can make you feel full, thus can significantly lower your calorie intake. In fact, almonds can be a good addition if you are following the keto diet. Its low carb and high-fat content fit perfectly with the ketogenic diet.
The health benefits of almonds are endless, and these nuts are delicious as well, making it a good addition to your diet for a healthy lifestyle.
Image credit courtesy of HealthAliciousNess/Flickr


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



